EMPOWERING THE DEVELOPMENT OF BIOPHARMACEUTICALS

NEWS & press RELEASES

CET-home-5

The USPTO Issues a Patent to Cellular Engineering Technologies for Producing a Safer Induced Pluripotent Stem Cell

​The patent awards Cellular Engineering Technologies the intellectual property to develop, manufacture and commercialize induced pluripotent stem cells that are...
CET-home-6

Cellular Engineering Technologies Receives Exclusivity to Use John Paul II Medical Research Institute’s Immortalized Human Stem Cells for Commercial Bio-Production Applications

The exclusive right grants Cellular Engineering Technologies the intellectual property to develop, manufacture and commercialize next generation bio-production of recombinant...
ers-genomics-logo

Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement.

DUBLIN, Ireland and Coralville, Iowa, 17 August 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational...

Subscribe To Our Newsletter

A short message on why the visitor should subscribe to the newsletter and what they are likely to read about

Publications that cite CET products: